目次

Table of Contents

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value Chain Analysis

Market Sizing
Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Botulinum toxins - Market size and forecast 2020-2025
Other therapeutics - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape
Overview

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW- Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape

Drivers, Challenges, and Trends
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption
Competitive Scenario

Vendor Analysis
Vendors covered
Market positioning of vendors
AbbVie Inc.
Akorn Inc.
Eisai Co. Ltd.
Galderma SA
Ipsen Pharma
Lannett Co. Inc.
Medytox Inc.
Merz Pharma GmbH and Co. KGaA
Revance Therapeutics Inc.
Supernus Pharmaceuticals Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research Methodology
List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Botulinum toxins - Market size and forecast 2020-2025 ($ million)
24: Botulinum toxins - Year-over-year growth 2020-2025 (%)
25: Other therapeutics - Market size and forecast 2020-2025 ($ million)
26: Other therapeutics - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AbbVie Inc. - Overview
48: AbbVie Inc. - Business segments
49: AbbVie Inc. - Key offerings
50: AbbVie Inc. - Key customers
51: AbbVie Inc. - Segment focus
52: Akorn Inc. - Overview
53: Akorn Inc. - Product and service
54: Akorn Inc. - Key offerings
55: Akorn Inc. - Key customers
56: Akorn Inc. - Segment focus
57: Eisai Co. Ltd. - Overview
58: Eisai Co. Ltd. - Business segments
59: Eisai Co. Ltd. - Key offerings
60: Eisai Co. Ltd. - Key customers
61: Eisai Co. Ltd. - Segment focus
62: Galderma SA - Overview
63: Galderma SA - Product and service
64: Galderma SA - Key offerings
65: Galderma SA - Key customers
66: Galderma SA - Segment focus
67: Ipsen Pharma - Overview
68: Ipsen Pharma - Business segments
69: Ipsen Pharma - Key offerings
70: Ipsen Pharma - Key customers
71: Ipsen Pharma - Segment focus
72: Lannett Co. Inc. - Overview
73: Lannett Co. Inc. - Business segments
74: Lannett Co. Inc. - Key offerings
75: Lannett Co. Inc. - Key customers
76: Lannett Co. Inc. - Segment focus
77: Medytox Inc. - Overview
78: Medytox Inc. - Business segments
79: Medytox Inc. - Key offerings
80: Medytox Inc. - Key customers
81: Medytox Inc. - Segment focus
82: Merz Pharma GmbH and Co. KGaA - Overview
83: Merz Pharma GmbH and Co. KGaA - Product and service
84: Merz Pharma GmbH and Co. KGaA - Key offerings
85: Merz Pharma GmbH and Co. KGaA - Key customers
86: Merz Pharma GmbH and Co. KGaA - Segment focus
87: Revance Therapeutics Inc. - Overview
88: Revance Therapeutics Inc. - Product and service
89: Revance Therapeutics Inc. - Key offerings
90: Revance Therapeutics Inc. - Key customers
91: Revance Therapeutics Inc. - Segment focus
92: Supernus Pharmaceuticals Inc. - Overview
93: Supernus Pharmaceuticals Inc. - Business segments
94: Supernus Pharmaceuticals Inc. - Key offerings
95: Supernus Pharmaceuticals Inc. - Key customers
96: Supernus Pharmaceuticals Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations